Patent: 5,605,690

✉ Email this page to a colleague

Summary for Patent: 5,605,690

Title:	Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor
Abstract:	A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR.
Inventor(s):	Jacobs; Cindy A. (Seattle, WA), Smith; Craig A. (Seattle, WA)
Assignee:	Immunex Corporation (Seattle, WA)
Application Number:	08/385,229
Patent Claims:	see list of patent claims

Details for Patent 5,605,690

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Immunex Corporation	ENBREL	etanercept	For Injection	103795	November 02, 1998	⤷ Sign Up	2014-02-25
Immunex Corporation	ENBREL	etanercept	For Injection	103795	May 27, 1999	⤷ Sign Up	2014-02-25
Immunex Corporation	ENBREL	etanercept	Injection	103795	September 27, 2004	⤷ Sign Up	2014-02-25
Immunex Corporation	ENBREL	etanercept	Injection	103795	February 01, 2007	⤷ Sign Up	2014-02-25
Immunex Corporation	ENBREL MINI	etanercept	Injection	103795	September 14, 2017	⤷ Sign Up	2014-02-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,605,690

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Austria	E131871	⤷ Sign Up
Austria	E242322	⤷ Sign Up
Australia	3970293	⤷ Sign Up
Australia	4920993	⤷ Sign Up
Australia	6178190	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.